Ventriculoperitoneal shunt tube infection and changing pattern of antibiotic sensitivity in neurosurgery practice: Alarming trends

Neurology India

Volumn 64, Issue 4, 2016, Pages 671-676

  Kumar, Vikas ^a   Shah, Ankit S ^a   Singh, Daljit ^a   Loomba, Poonam S ^a   Singh, Hukum ^a   Jagetia, Anita ^a  

^a G B Pant Institute of Postgraduate Medical Education and Research   (India)

Author keywords

Antibiotic resistance; Hydrocephalus; Infection; Ventriculoperitoneal shunt

Indexed keywords

IMIPENEM; MEROPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BRAIN PSEUDOTUMOR; BRAIN VENTRICLE PERITONEUM SHUNT; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONGENITAL HYDROCEPHALUS; DANDY WALKER SYNDROME; ENCEPHALOCELE; ESCHERICHIA COLI; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; MYCOBACTERIUM TUBERCULOSIS; NEUROCYSTICERCOSIS; NEUROSURGERY; RETROSPECTIVE STUDY; SHUNT INFECTION; STAPHYLOCOCCUS AUREUS; TUBERCULOUS MENINGITIS; BACTERIUM; CLINICAL PRACTICE; INFECTION; ISOLATION AND PURIFICATION;

ANTI-BACTERIAL AGENTS; BACTERIA; FEMALE; HUMANS; INFECTION; MALE; NEUROSURGICAL PROCEDURES; PRACTICE PATTERNS, PHYSICIANS'; VENTRICULOPERITONEAL SHUNT;

EID: 84978865094     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.185408     Document Type: Article

References (45)

1. Baru JS, Bloom DA, Muraszko K, Koop CE. John Holter's shunt. J Am Coll Surg 2001;192:79-85.
2. Aoyama Y, Kinoshita Y, Yokota A, Hamada T. Neuronal damage in hydrocephalus and its restoration by shunt insertion in experimental hydrocephalus: A study involving the neurofilament-immunostaining method. J Neurosurg 2006;104(5 Suppl):332-9.
3. Del Bigio MR. Cellular damage and prevention in childhood hydrocephalus. Brain Pathol 2004;14:317-24.
4. Farahmand D, Hilmarsson H, Högfeldt M, Tisell M. Perioperative risk factors for short term shunt revisions in adult hydrocephalus patients. J Neurol Neurosurg Psychiatry 2009;80:1248-53.
5. Kandasamy J, Dwan K, Hartley JC, Jenkinson MD, Hayhurst C, Gatscher S, et al. Antibiotic-impregnated ventriculoperitoneal shunts - A multi-centre British pediatric neurosurgery group (BPNG) study using historical controls. Childs Nerv Syst 2011;27:575-81.
6. Lee L, King NK, Kumar D, Ng YP, Rao J, Ng H, et al. Use of programmable versus nonprogrammable shunts in the management of hydrocephalus secondary to aneurysmal subarachnoid hemorrhage: A retrospective study with cost-benefit analysis. J Neurosurg 2014;121:899-903.
7. Lemcke J, Meier U. Improved outcome in shunted iNPH with a combination of a Codman Hakim programmable valve and an Aesculap-Miethke Shunt Assistant. Cent Eur Neurosurg 2010;71:113-6.
8. Lemcke J, Meier U, Müller C, Fritsch M, Eymann R, Kiefer M, et al. Is it possible to minimize overdrainage complications with gravitational units in patients with idiopathic normal pressure hydrocephalus? Protocol of the randomized controlled SVASONA Trial (ISRCTN51046698). Acta Neurochir Suppl 2010;106:113-5.
9. Reddy GK, Bollam P, Caldito G. Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus. World Neurosurg 2014;81:404-10.
10. Sciubba DM, Noggle JC, Carson BS, Jallo GI. Antibiotic-impregnated shunt catheters for the treatment of infantile hydrocephalus. Pediatr Neurosurg 2008;44:91-6.
11. Borgbjerg BM, Gjerris F, Albeck MJ, Hauerberg J, Børgesen SE. Frequency and causes of shunt revisions in different cerebrospinal fluid shunt types. Acta Neurochir (Wien) 1995;136:189-94.
12. Cochrane DD, Kestle JR. The influence of surgical operative experience on the duration of first ventriculoperitoneal shunt function and infection. Pediatr Neurosurg 2003;38:295-301.
13. Di Rocco C, Marchese E, Velardi F. A survey of the first complication of newly implanted CSF shunt devices for the treatment of nontumoral hydrocephalus. Cooperative survey of the 1991-1992 Education Committee of the ISPN. Childs Nerv Syst 1994;10:321-7.
14. Farahmand D, Hilmarsson H, Högfeldt M, Tisell M. Perioperative risk factors for short term shunt revisions in adult hydrocephalus patients. J Neurol Neurosurg Psychiatry 2009;80:1248-53.
15. McGirt MJ, Buck DW 2nd, Sciubba D, Woodworth GF, Carson B, Weingart J, et al. Adjustable vs set-pressure valves decrease the risk of proximal shunt obstruction in the treatment of pediatric hydrocephalus. Childs Nerv Syst 2007;23:289-95.
16. Notarianni C, Vannemreddy P, Caldito G, Bollam P, Wylen E, Willis B, et al. Congenital hydrocephalus and ventriculoperitoneal shunts: Influence of etiology and programmable shunts on revisions. J Neurosurg Pediatr 2009;4:547-52.
17. Stein SC, Guo W. Have we made progress in preventing shunt failure? A critical analysis. J Neurosurg Pediatr 2008;1:40-7.
18. Tuli S, Drake J, Lawless J, Wigg M, Lamberti-Pasculli M. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus. J Neurosurg 2000;92:31-8.
19. Wu Y, Green NL, Wrensch MR, Zhao S, Gupta N.Ventriculoperitoneal shunt complications in California: 1990 to 2000. Neurosurgery 2007;61:557-63
20. Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, et al. Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 2000;33:230-6.
21. Blount JP, Campbell JA, Haines SJ. Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin N Am 1993;4:633-56.
22. Bhatnagar V, George J, Mitra DK, Upadhyaya P. Complications of cerebrospinal fluid shunts. Indian J Pediatr 1983;50:133-8.
23. Kaufman BA, Mc Lone DG. Infection of cerebrospinal fluid shunts.In: Scheld WM, Whitley RJ, Durack DT (editors). Infection of the Central Nervous System. Raven Press: New York; 1991. pp. 561-85.
24. Morrice JJ, Young DG. Bacterial colonization of Holter valves: A ten-year survey. Dev Med Child Neurol 1974;16(Suppl 32):85-90.
25. Olsen L, Frykberg T. Complications in the treatment of hydrocephalus in children. A comparison of ventriculoatrial and ventriculoperitoneal shunts in a 20-year material. Acta Pediatr Scand 1983;72:385-90.
26. Schoenbaum SC, Gardner P, Shillito J. Infections of the cerebrospinal fluid shunts: Epidemiology, clinical manifestation, and therapy. J Infect Dis 1975;131:543-52.
27. Sells CJ, Shurtleff DB, Loeser JD. Gram-negative cerebrospinal fluid shunt-associated infections. Pediatrics1977;59:614-8.
28. Singh A, Vajpeyi I N. Comparative study of lumboperitoneal shunt versus ventriculoperitoneal shunt in post meningitis communicating hydrocephalus in children. Neurol India 2013;61:513-6
29. Holt RJ. Bacteriological studies in colonized ventriculoatrial shunts. Dev Med Child Neurol Suppl 1970;22(Suppl 22):83-7.
30. Ersahin Y, McLone DJ, Storrs BB, Yogev R. Review of 3017 procedures for the management of hydrocephalus in children. Concepts Pediatr Neurosurg 1989;9:21-8.
31. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 2003;36:858-62.
32. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: A prospective study of risk factors. J Neurosurg 2001;94:195-201.
33. Al-Tamimi YZ, Sinha P, Chumas PD, Crimmins D, Drake J, Kestle J, et al. Ventriculoperitoneal shunt 30-day failure rate: A retrospective international cohort study. Neurosurgery 2014;74:29-34.
34. Aubert G, Jacquemond G, Pozzetto B, Duthel R, Baylot D, Brunon J, et al. Pharmacokinetic evidence of imipenem efficacy in the treatment of Klebsiella pneumonae nosocomial meningitis. J Antimicrob Chemother 1991;28:316-7.
35. Odio C, McCracken GH Jr, Nelson JD. CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child 1984;138:1103-8.
36. Enger PØ, Svendsen F, Sommerfelt K, Wester K. Shunt revisions in children - Can they be avoided? Experiences from a population-based study. Pediatr Neurosurg 2005;41:300-4.
37. Kontny U, Höfling B, Gutjahr P, Voth D, Schwarz M, Schmitt HJ. CSF shunt infections in children. Infection 1993;21:89-92.
38. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 2003;36:858-62.
39. Stamos JK, Kaufman BA, Yogev R. Ventriculoperitoneal shunt infections with gram-negative bacteria. Neurosurgery 1993;33:858-62.
40. Wang KC, Lee HJ, Sung JN, Cho BK. Cerebrospinal fluid shunt infection in children: Efficiency of management protocol, rate of persistent shunt colonization, and significance of 'off-antibiotics' trial. Childs Nerv Syst 1999;15:38-44
41. Palur R, Rajshekhar V, Chandy MJ, Joseph T, Abraham J. Shunt surgery for hydrocephalous in tubercular meningitis: A long-term follow-up study. J Neurosurg 1991;74:64-9.
42. Agrawal D, Gupta A, Mehta VS. Role of shunt surgery in pediatric tubercular meningitis with hydrocephalus. Indian Pediatr 2005;42:245-50.
43. Sil K, Chatterjee S. Shunting in tuberculous meningitis: A neurosurgeon's nightmare. Childs Nerv Syst 2008;24:1029-32.
44. Kestle JR, Garton HJ, Whitehead WE, Drake JM, Kulkarni AV, Cochrane DD, et al. Management of shunt infections: A multicenter pilot study. J Neurosurg 2006;105(3 Suppl):177-81.
45. Kulkarni AV, Rabin D, Lamberti-Pasculli M, Drake JM. Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg 2001;35:66-71.